Sort

Search

01/08/2022 Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
Chaparro, M, Baston-Rey, I, Salgado, EF, Garcia, JG, Ramos, L, Palomares, MTDL, Arguelles-Arias, F, Flores, EI, Cabello, M, Iturria, SR, Ortiz, AN, Charro, M, Ginard, D, Sadornil, CD, Ochoa, OM, Busquets, D, Iyo, E, Casbas, AG, de la Piscina, PR, Bosca-Watts, MM, Arroyo, M, Garcia, MJ, Hinojosa, E, Gordillo, J, Montiel, PM, Jimenez, BV, Ivorra, CQ, Moron, JMV, Huguet, JM, Gonzalez-Lama, Y, Santos, AIM, Amo, VM, Arranz, MDM, Bermejo, F, Cadilla, JM, de Celix, CR, Salazar, PF, San Roman, AL, Jimenez, N, Garcia-Lopez, S, Figuerola, A, Jimenez, I, Cerezo, FJM, Taxonera, C, Varela, P, de Francisco, R, Monfort, D, Arriero, GM, Hernandez-Camba, A, Alonso, FJG, Van Domselaar, M, Pajares-Villarroya, R, Nunez, A, Moranta, FR, Marin-Jimenez, I, Alonso, VR, Rodriguez, MDM, Camo-Monterde, P, Tercero, IG, Navarro-Llavat, M, Garcia, LA, Cruz, DH, Kloss, S, Passey, A, Novella, C, Vispo, E, Barreiro-de Acosta, M, Gisbert, JP. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab. Journal of Clinical Medicine. 2022; 11(15)DOI:10.3390/jcm11154518. PMID:35956133. IF:3.900(Q2/4D).
01/08/2022 Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, Macgowan, A, Grier, S, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, de Cueto, M, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez-Martinez, L, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstein, Y, Leibovici, L, Yahav, D. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study. Infectious Diseases and Therapy. 2022; 11(4)DOI:10.1007/s40121-022-00657-1. PMID:35612693. IF:5.400(Q2/3D).
01/08/2022 Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019)
Badia-Cebada, L, Penafiel, J, Lopez-Contreras, J, Pomar, V, Martinez, JA, Santana, G, Cuquet, J, Montero, MM, Hidalgo-Lopez, C, Andres, M, Gimenez, M, Quesada, MD, Vaque, M, Iftimie, S, Gudiol, C, Perez, R, Coloma, A, Marron, A, Barrufet, P, Marimon, M, Lerida, A, Claros, M, Ramirez-Hidalgo, MF, Pardo, GG, Martinez, MJ, Chamarro, EL, Jimenez-Martinez, E, Hornero, A, Limon, E, Lopez, M, Calbo, E, Pujol, M, Gasch, O. Decreased mortality among patients with catheter- related bloodstream infections at Catalan hospitals (2010-2019). JOURNAL OF HOSPITAL INFECTION. 2022; 126DOI:10.1016/j.jhin.2022.05.009. PMID:35594988. IF:6.900(Q1/2D).
01/08/2022 Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?
Castellví I., Vidal S., Valenzuela C.. Autoimmunity in the Study of Interstitial Lung Disease: Are Serological Test Enough?. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.016. PMID:35312568. IF:8.000(Q1/2D).